Target intelligence / Profile preview

Cytomegalovirus antigen-positive host cells

Molecular classification
Other
01

Overview

Cytomegalovirus antigen-positive host cells are human or animal cells that have been infected by cytomegalovirus, resulting in the presentation of CMV antigens on their surface or within the cell. These antigens are detected using immunological assays for diagnostic or research purposes. The presence of such cells is used as evidence of active or latent CMV infection, particularly in the context of immunosuppressed patients (e.g., transplant recipients, HIV/AIDS patients), and in congenital CMV disease. This term does not refer to a specific molecular receptor, enzyme, or protein; rather, it indicates a population of cells containing or expressing viral molecules. Antiviral drugs target viral processes inside these cells but do not directly target the cells themselves[7][1][4]. As the phrase does not specify a single, canonical therapeutic target, it is not considered a valid molecular drug target by conventional pharmacological definitions.

Other names
CMV-infected cellHCMV-positive cell
02

Mechanism of action

Inhibition of viral DNA polymerase or terminase complex within CMV-infected (antigen-positive) cells, preventing viral DNA replication and virion production

03

Biological functions

Host for viral replicationImmune evasion and immune activationViral latency reservoir
04

Disease associations

InfectionImmune system modulationCongenital disease (via vertical transmission)
05

Safety considerations

Off-target effects of antivirals in host cells (myelosuppression, nephrotoxicity)Drug resistance in CMVHost immunosuppression increasing susceptibility to opportunistic infections
06

Interacting drugs

Ganciclovir

4 more in the full profile.

07

Biomarkers

Detectable CMV antigens (e.g., immediate early antigen, pp65 antigen) in blood or tissuePCR-detectable CMV DNA

Beyond the preview

Go deeper on Cytomegalovirus antigen-positive host cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytomegalovirus antigen-positive host cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call